These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11136320)
1. Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer. Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT Br J Surg; 2001 Jan; 88(1):101-6. PubMed ID: 11136320 [TBL] [Abstract][Full Text] [Related]
2. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Graham RA; Wang S; Catalano PJ; Haller DG Ann Surg; 1998 Jul; 228(1):59-63. PubMed ID: 9671067 [TBL] [Abstract][Full Text] [Related]
3. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group. Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947 [TBL] [Abstract][Full Text] [Related]
4. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important. Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771 [TBL] [Abstract][Full Text] [Related]
5. Yield of routine imaging after curative colorectal cancer treatment. Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580 [TBL] [Abstract][Full Text] [Related]
6. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Peethambaram P; Weiss M; Loprinzi CL; Novotny P; O'Fallon JR; Erlichman C; O'Connell MJ; Laurie JA Oncology; 1997; 54(4):287-92. PubMed ID: 9216852 [TBL] [Abstract][Full Text] [Related]
8. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer. Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699 [TBL] [Abstract][Full Text] [Related]
9. Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study. Borie F; Daurès JP; Millat B; Trétarre B J Gastrointest Surg; 2004; 8(5):552-8. PubMed ID: 15239990 [TBL] [Abstract][Full Text] [Related]
10. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D; JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen C JAMA; 1993 Aug; 270(8):943-7. PubMed ID: 8141873 [TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemotherapy improves chances of survival in curative surgery of colon cancer, Dukes' stage C]. Porschen R; Stremmel W Z Gastroenterol; 1990 Jul; 28(7):375-6. PubMed ID: 2238769 [No Abstract] [Full Text] [Related]
13. A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma. Smith RD; Hall J; Gurney H; Harnett PR Med J Aust; 1993 Mar; 158(5):319-22. PubMed ID: 8474372 [TBL] [Abstract][Full Text] [Related]
14. Prospective monitoring trial for carcinoma of colon and rectum after surgical resection. Wanebo HJ; Llaneras M; Martin T; Kaiser D Surg Gynecol Obstet; 1989 Dec; 169(6):479-87. PubMed ID: 2683153 [TBL] [Abstract][Full Text] [Related]
16. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627 [TBL] [Abstract][Full Text] [Related]
17. Role of adjuvant therapy in colorectal cancer. Hesketh PJ; Bulger KN Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581 [TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. Song S; Hong JC; McDonnell SE; Koong AC; Minsky BD; Chang DT; Liauw SL Ann Surg Oncol; 2012 Aug; 19(8):2471-6. PubMed ID: 22327251 [TBL] [Abstract][Full Text] [Related]
19. [Prospective follow-up study of radically resected colorectal carcinoma. Status after 5 years]. Metzger U; Bronz K; Bühler H; Dolder A; Seefeld U; Hollinger A; Largiadèr F Schweiz Med Wochenschr; 1985 Jul; 115(29):1001-4. PubMed ID: 4048893 [TBL] [Abstract][Full Text] [Related]